Ficlatuzumab |
| Catalog No.GC69110 |
Ficlatuzumab es un anticuerpo monoclonal dirigido contra el factor de crecimiento hepatocelular humano (HGF). Ficlatuzumab puede bloquear la activación de la vía de señalización HGF/c-Met, inhibiendo así la proliferación, migración e invasión celular mediada por el receptor c-Met en células cancerosas.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1174900-84-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Ficlatuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Ficlatuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *